57499-33-9

Upstream product

• 7536-58-5 BOC-L-aspartic acid 4-benzyl ester 
• 541-41-3 chloroformic acid ethyl ester 
• 593-51-1 methylamine hydrochloride 

Downstream Products

• 549531-75-1 phenylmethyl (3S)-3-({[(1,1-dimethylethyl)oxy]carbonyl}amino)-4-(methylamino)-4-thioxobutanoate 
• 216311-52-3 -L-aspartic acid 1-methylamide 5-benzyl ester 
• 216309-90-9 -L-aspartic acid 1-methylamide 5-benzyl ester 
• 216309-88-5 N-(tert-butoxycarbonyl)-D-seryl-L-aspartic acid 1-methylamide 4-benzyl ester 
• 167173-51-5 3-amino-N-methyl-succinamic acid benzyl ester 

Relevant academic research and scientific papers

PYRROLIDINONE ANILINES AS PROGESTERONE RECEPTOR MODULATORS

The present invention relates to a compound represented by the following formula: or a pharmaceutically acceptable salt thereof, or a solvate thereof, or a combination thereof, wherein R1, R2, and X are as defined herein. Compounds o

Fucose derivatives, drugs containing the same as active ingredient, and intermediates for producing the same

A compound of the formula (I): STR1 wherein X1 is a group of one of the following formulae (1), (2) and (3): STR2 R1 is a branched long chain alkyl group, R2 is --CONHR3, a carboxyl group or a hydrogen atom, n is an integer of 0, 1 or 2, and R3 is a lower alkyl group or a phenyl group, or a pharmaceutically acceptable salt thereof, which is useful as a selectin inhibitor, and can be used in the prophylaxis or treatment of various inflammatory diseases such as inflammatory dermatitis (e.g., atopic dermatitis, contact hypersensitivity, photodermatosis, etc.), autoimmune chronic diseases (e.g. rheumatoid arthritis, chronic thyroiditis, etc.), and ischemia-reperfusion injury.